文献速递糖尿病

血浆肾上腺髓质素、ADM基因等位变异与2型糖尿病患者下肢截肢风险

Plasma Adrenomedullin, Allelic Variations in the ADM Gene, and Risk for Lower-Limb Amputation in People With Type 2 Diabetes.
PubMed 文献 · Diabetes Care · 2022-01-01

在DIABHYCAR和SURDIAGENE队列的4375例2型糖尿病患者中,血浆MR-proADM三分位越高,随访期间下肢截肢需求越高(T1 1.0%、T2 2.3%、T3 4.4%);T3 vs T1的校正HR为4.40(95%CI 2.30-8.88)。ADM基因区4个SNP与基线MR-proADM浓度及随访期间下肢截肢相关,孟德尔随机化模式支持ADM与下肢截肢关联的因果性。

要点

  • 血浆MR-proADM三分位T1、T2、T3的下肢截肢需求分别为1.0%、2.3%、4.4%(P<0.0001)。
  • 校正后T3 vs T1的下肢截肢HR为4.40(95%CI 2.30-8.88,P<0.0001)。
  • ADM基因区4个SNP与基线MR-proADM浓度及随访期间下肢截肢相关。

核心结论

  • 在2型糖尿病患者中观察到血浆MR-proADM与下肢截肢相关,ADM基因SNP与血浆MR-proADM及下肢截肢相关,孟德尔随机化模式支持ADM与下肢截肢关联的因果性。

研究设计与样本

  • 研究纳入DIABHYCAR和SURDIAGENE队列共4375例参与者(男性68%,平均年龄66岁,平均糖尿病病程12年,中位随访5.3年)。
  • 采用免疫荧光法测定血浆midregional proadrenomedullin(MR-proADM,作为ADM的替代指标),并对ADM基因区5个单核苷酸多态性(SNP)进行基因分型。

主要发现

  • 随访期间下肢截肢需求随血浆MR-proADM三分位升高而增加:T1为1.0%、T2为2.3%、T3为4.4%(P<0.0001)。
  • Cox多变量分析中,T3 vs T1的下肢截肢校正风险比(95%CI)为4.40(2.30-8.88)(P<0.0001)。
  • MR-proADM显著改善了下肢截肢风险分层的指标。
  • 4个SNP与基线血浆MR-proADM浓度及随访期间下肢截肢相关,与较高MR-proADM相关的等位基因与下肢截肢风险增加相关。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Patients with diabetes have an increased risk for lower-limb amputation (LLA), but biomarkers to assess risk of LLA are lacking. Adrenomedullin (ADM) is a vasodilator peptide that also plays a role in fluid and electrolyte homeostasis in the kidney, increasing natriuresis and diuresis. ADM was shown to be associated with cardiovascular and renal events in diabetes, but it was not investigated in terms of LLA risk. We investigated the hypothesis that ADM is associated with LLA in people with type 2 diabetes. RESEARCH DESIGN AND METHODS: We studied 4,375 participants in the DIABHYCAR and SURDIAGENE cohorts (men, 68%; mean 66 years of age; mean duration of diabetes 12 years; and median follow-up 5.3 years). Plasma midregional proadrenomedullin (MR-proADM; a surrogate for ADM) was measured by immunofluorescence. Five single nucleotide polymorphisms (SNPs) in the ADM gene region were genotyped. RESULTS: LLA requirement during follow-up by increasing tertiles of plasma MR-proADM distribution was 1.0% (tertile 1 [T1]), 2.3% (T2), and 4.4% (T3) (P < 0.0001). In Cox multivariate analysis, the adjusted hazard ratio (95% CI) for LLA was 4.40 (2.30-8.88) (P < 0.0001) for T3 versus T1. Moreover, MR-proADM significantly improved indices for risk stratification of LLA. Four SNPs were associated with plasma MR-proADM concentration at baseline and with LLA during follow-up. Alleles associated with higher MR-proADM were associated with increased LLA risk. CONCLUSIONS: We observed associations of plasma MR-proADM with LLA and of ADM SNPs with plasma MR-proADM and with LLA in people with type 2 diabetes. This pattern of Mendelian randomization supports the causality of the association of ADM with LLA.

来源:Diabetes Care,查看原文。版权归原作者所有。

引用

  1. Potier L, Mohammedi K, Saulnier PJ, et al. Plasma Adrenomedullin, Allelic Variations in the ADM Gene, and Risk for Lower-Limb Amputation in People With Type 2 Diabetes. Diabetes Care. 2022. PMID: 35583678. doi:10.2337/dc21-2638

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。